{
    "@context": "https://schema.org",
    "@type": "Article",
    "headline": "What Does DEA’s Proposed Special Registration Framework for Tele-prescribing Controlled Substances Mean?",
    "url": "https://www.lexblog.com/2025/02/03/what-does-deas-proposed-special-registration-framework-for-tele-prescribing-controlled-substances-mean/",
    "identifier": {
        "@type": "PropertyValue",
        "name": "LexBlog Library record",
        "value": "LEX-WK-KHDFFKMD",
        "url": "https://www.lexblog.com/lib/KHDFFKMD/"
    },
    "datePublished": "2025-02-03T22:30:41-05:00",
    "dateModified": "2025-02-04T06:35:13-05:00",
    "author": {
        "@type": "Person",
        "name": "Liyun Huang, Thomas W. Greeson"
    },
    "sourceOrganization": {
        "@type": "Organization",
        "name": "Reed Smith LLP"
    },
    "organizationScope": "at-publication",
    "isPartOf": "Health Industry Washington Watch",
    "about": "Health Care and Life Sciences",
    "sourceUrl": "https://www.healthindustrywashingtonwatch.com/?p=26401",
    "sourceStability": "may-move"
}